# Journey Medical Corporation (DERM)

Source: https://www.quantisnow.com/company/DERM
Generated: 2026-11-13T04:46:46.322Z

- Ticker: DERM
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2021
- SEC CIK: 0001867066
- Website: journeymedicalcorp.com

## About

Journey Medical Corporation develops and commercializes pharmaceutical products for the treatment of dermatological conditions. It markets generic prescription drugs for dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for the treatment of severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

## Latest DERM news and filings

- 2026-11-12 21:35 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Journey Medical Corporation](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-journey-medical-corporation-6788505)
- 2026-11-12 21:05 UTC [SEC Form 8-K] [Journey Medical Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/journey-medical-corporation-filed-sec-form-8-k-results-of-operations-6787799)
- 2026-11-12 21:01 UTC [Earnings] [Journey Medical Corporation Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights](https://www.quantisnow.com/insight/journey-medical-corporation-reports-third-quarter-2026-financial-results-and-6787477)
- 2026-11-05 13:30 UTC [Earnings Date] [Journey Medical Corporation to Announce Third Quarter 2026 Financial Results on November 12, 2026](https://www.quantisnow.com/insight/journey-medical-corporation-to-announce-third-quarter-2026-financial-results-6774990)
- 2026-10-09 19:35 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Journey Medical Corporation](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-journey-medical-corporation-6742762)
- 2026-09-08 20:05 UTC [Conference Announcement] [Journey Medical Corporation to Participate in September 2026 Investor Conferences](https://www.quantisnow.com/insight/journey-medical-corporation-to-participate-in-september-2026-investor-conferences-6708206)
- 2026-08-19 20:05 UTC [Leadership Update] [Longeveron Appoints Nirav Jhaveri as Chief Financial Officer](https://www.quantisnow.com/insight/longeveron-appoints-nirav-jhaveri-as-chief-financial-officer-6688276)
- 2026-08-12 20:40 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Journey Medical Corporation](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-journey-medical-corporation-6678294)
- 2026-08-12 20:05 UTC [SEC Form 8-K] [Journey Medical Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/journey-medical-corporation-filed-sec-form-8-k-results-of-operations-6677825)
- 2026-08-12 20:01 UTC [Earnings Date] [Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights](https://www.quantisnow.com/insight/journey-medical-corporation-reports-second-quarter-2026-financial-results-and-6677664)
- 2026-08-05 12:30 UTC [Earnings Date] [Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026](https://www.quantisnow.com/insight/journey-medical-corporation-to-announce-second-quarter-2026-financial-results-6664179)
- 2026-07-15 21:16 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Journey Medical Corporation](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-journey-medical-corporation-6638610)
- 2026-07-02 20:07 UTC [SEC Form 4] [Director Toledano Miranda Jayne was granted 50,000 shares, increasing direct ownership by 42% to 168,618 units (SEC Form 4)](https://www.quantisnow.com/insight/director-toledano-miranda-jayne-was-granted-50000-shares-increasing-direct-6625219)
- 2026-07-02 20:06 UTC [SEC Form 4] [Director Smith Justin Adam was granted 50,000 shares, increasing direct ownership by 28% to 231,618 units (SEC Form 4)](https://www.quantisnow.com/insight/director-smith-justin-adam-was-granted-50000-shares-increasing-direct-6625179)
- 2026-07-02 20:05 UTC [SEC Form 4] [Director Herskowitz Neil was granted 50,000 shares, increasing direct ownership by 42% to 168,618 units (SEC Form 4)](https://www.quantisnow.com/insight/director-herskowitz-neil-was-granted-50000-shares-increasing-direct-ownership-6625106)
- 2026-06-29 20:05 UTC [SEC Form 4] [Director Toledano Miranda Jayne was granted 10,000 shares, increasing direct ownership by 9% to 118,618 units (SEC Form 4)](https://www.quantisnow.com/insight/director-toledano-miranda-jayne-was-granted-10000-shares-increasing-direct-6618905)
- 2026-06-26 20:20 UTC [SEC Form 4] [Director Smith Justin Adam was granted 10,000 shares, increasing direct ownership by 6% to 181,618 units (SEC Form 4)](https://www.quantisnow.com/insight/director-smith-justin-adam-was-granted-10000-shares-increasing-direct-6617439)
- 2026-06-26 20:18 UTC [SEC Form 4] [Director Herskowitz Neil was granted 10,000 shares, increasing direct ownership by 9% to 118,618 units (SEC Form 4)](https://www.quantisnow.com/insight/director-herskowitz-neil-was-granted-10000-shares-increasing-direct-ownership-6617428)
- 2026-06-26 20:17 UTC [SEC Form 4] [Director Pearce Michael Cooper was granted 10,000 shares, increasing direct ownership by 17% to 67,173 units (SEC Form 4)](https://www.quantisnow.com/insight/director-pearce-michael-cooper-was-granted-10000-shares-increasing-direct-6617407)
- 2026-06-26 20:14 UTC [SEC Form 4] [Director Rosenwald Lindsay A Md was granted 10,000 shares, increasing direct ownership by 5% to 221,146 units (SEC Form 4)](https://www.quantisnow.com/insight/director-rosenwald-lindsay-a-md-was-granted-10000-shares-increasing-6617365)
- 2026-06-26 00:01 UTC [SEC Form 8-K] [Journey Medical Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/journey-medical-corporation-filed-sec-form-8-k-submission-of-matters-6616598)
- 2026-05-19 20:45 UTC [Conference Announcement] [Journey Medical Corporation to Participate in A.G.P.'s Annual Virtual Healthcare Conference](https://www.quantisnow.com/insight/journey-medical-corporation-to-participate-in-agps-annual-virtual-healthcare-6563123)
- 2026-05-13 20:33 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Journey Medical Corporation](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-journey-medical-corporation-6551326)
- 2026-05-13 20:06 UTC [SEC Form 8-K] [Journey Medical Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/journey-medical-corporation-filed-sec-form-8-k-results-of-operations-6550746)
- 2026-05-13 20:01 UTC [Earnings Date] [Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights](https://www.quantisnow.com/insight/journey-medical-corporation-reports-first-quarter-2026-financial-results-and-6550561)
- 2026-05-06 20:01 UTC [Earnings Date] [Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026](https://www.quantisnow.com/insight/journey-medical-corporation-to-announce-first-quarter-2026-financial-results-6535066)
- 2026-04-30 20:09 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Journey Medical Corporation](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-journey-medical-corporation-6524363)
- 2026-04-30 20:06 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Journey Medical Corporation](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-journey-medical-corporation-6524206)
- 2026-04-24 21:29 UTC [SEC Form 4] [Chief Operating Officer Alloush Ramsey was granted 46,863 shares, increasing direct ownership by 8% to 598,543 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-operating-officer-alloush-ramsey-was-granted-46863-shares-increasing-6515061)
- 2026-04-24 21:28 UTC [SEC Form 4] [CFO Benesch Joseph was granted 28,907 shares, increasing direct ownership by 12% to 261,371 units (SEC Form 4)](https://www.quantisnow.com/insight/cfo-benesch-joseph-was-granted-28907-shares-increasing-direct-ownership-6515053)
- 2026-04-24 21:27 UTC [SEC Form 4] [President & CEO Maraoui Claude was granted 49,277 shares, increasing direct ownership by 2% to 2,435,990 units (SEC Form 4)](https://www.quantisnow.com/insight/president-ceo-maraoui-claude-was-granted-49277-shares-increasing-direct-6515046)
- 2026-04-21 21:20 UTC [SEC Form 8-K] [Journey Medical Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/journey-medical-corporation-filed-sec-form-8-k-other-events-financial-6508953)
- 2026-04-21 12:30 UTC [Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™](https://www.quantisnow.com/insight/journey-medical-corporation-secures-contract-with-third-major-gpo-for-6507820)
- 2026-04-06 21:54 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Journey Medical Corporation](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-journey-medical-corporation-6489869)
- 2026-03-25 20:05 UTC [SEC Form 8-K] [Journey Medical Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/journey-medical-corporation-filed-sec-form-8-k-results-of-operations-6468824)
- 2026-03-25 20:01 UTC [Earnings Date] [Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights](https://www.quantisnow.com/insight/journey-medical-corporation-reports-full-year-2025-financial-results-and-recent-6468744)
- 2026-03-18 12:30 UTC [Earnings Date] [Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026](https://www.quantisnow.com/insight/journey-medical-corporation-to-announce-year-end-2025-financial-results-6455421)
- 2026-01-23 21:06 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Journey Medical Corporation](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-journey-medical-corporation-6359129)
- 2026-01-23 21:05 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Journey Medical Corporation](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-journey-medical-corporation-6359112)
- 2026-01-22 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Journey Medical Corporation](https://www.quantisnow.com/insight/sec-form-effect-filed-by-journey-medical-corporation-6356922)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/DERM
- Earnings history: https://www.quantisnow.com/earnings/DERM
- Dividend history: https://www.quantisnow.com/dividends/DERM
- Insider transactions: https://www.quantisnow.com/insiders/DERM
- Options chain: https://www.quantisnow.com/options/DERM
- SEC 8-K filings only: https://www.quantisnow.com/company/DERM/8-k
- RSS and alerts for DERM: https://www.quantisnow.com/docs/rss-feeds.md